COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 17 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 605,437 | $4,928,000 | 9.60% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 693,066 | $5,544,000 | 0.57% |
| VILLERE ST DENIS J & CO LLC | 266,897 | $2,135,000 | 0.16% |
| FNY Investment Advisers, LLC | 5,000 | $40,000 | 0.03% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 71,810 | $585,000 | 0.03% |
| SIMON QUICK ADVISORS, LLC | 15,676 | $139,000 | 0.02% |
| ARK Investment Management | 235,660 | $2,192,000 | 0.01% |
| Cohanzick Management, LLC | 2,000 | $16,000 | 0.01% |
| BROWN ADVISORY INC | 77,349 | $619,000 | 0.00% |
| Private Advisor Group, LLC | 12,862 | $103,000 | 0.00% |